Small caps did an article on today’s Ann. Note the following sentence:
Specifically, Camargo will assist Incannex to develop the non-clinical, clinical, pharmacological and biopharmaceutical strategy to be proposed to the FDA.
https://*********.com.au/incannex-healthcare-reveals-positive-in-vivo-results-meeting-fda/
- Forums
- ASX - By Stock
- IHL
- Ann: Positive IHL-675A in vivo results and FDA Pathway
Ann: Positive IHL-675A in vivo results and FDA Pathway, page-55
-
- There are more pages in this discussion • 70 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online